There is just too much anecdotal info pointing in the direction of subq being inferior to IM in a lot of men. These are men who have tested over time, and we cannot discount the info provided. The total sample size over multiple forums is a LOT. This anomaly cannot be ignored. To all those in difficulty dialing in, ensure IM is the method used first and foremost.
There will always be those who are too stubborn and too set in their ways to realise this.
I am being treated by one of the leading urologists in Canada.
Sub-q test injections have been used by some doctors since the early 2000s and my
urologist was one of the early pioneers involved in a 2005 pilot study and has been treating his patients using subcutaneous testosterone injections for almost 15 years!
He treats hundreds of men and a majority are doing sub-q.
Other studies have come out since 2005 backing the effectiveness of sub-q trt injections.
Subcutaneous Testosterone: An Effective Delivery Mechanism for Masculinizing Young Transgender Men (2014)
www.excelmale.com
I have been on trt for almost 5 years and strictly inject sub-q into abdominal fat.....my TT/FT levels have always been consistently in the high-end!
STABLE TESTOSTERONE LEVELS ACHIEVED WITH SUBCUTANEOUS TESTOSTERONE INJECTIONS (2005)
M.B. Greenspan, C.M. Chang
Division of Urology, Department of Surgery, McMaster University,
Hamilton, ON, Canada
Objectives: The preferred technique of androgen replacement has been intramuscular (IM) testosterone, but wide variations in testosterone levels are often seen.
Subcutaneous (SC) testosterone injection is a novel approach; however, its physiological effects are unclear. We, therefore, investigated the sustainability of stable testosterone levels using SC therapy.
Patients and methods: Between May and September 2005, we conducted a small pilot study involving 10 male patients with symptomatic late-onset hypogonadism.
Every patient had been stable on TE 200 mg IM for 1 year.
*Patients were instructed to self-inject with testosterone enanthate (TE) 100 mg SC (DELATESTRYL 200 mg/cc, Theramed Corp, Canada) into the anterior abdomen once weekly. Some patients were down-titrated to 50 mg based on their total testosterone (T) at 4 weeks.
Informed consent was obtained as SC testosterone administration is not officially approved by Health Canada.
T levels were measured before and 24 hours after injection during weeks 1, 2, 3, and 4, and 96 hours after injection in weeks 6 and 8.
At week 12, PSA, CBC, and T levels were measured, however; the week 12 data are still being collected.
Results: Prior to initiation of SC therapy, T was 19.14+3.48 nmol/l, hemoglobin 15.8+1.3 g/dl, hematocrit 0.47+0.02, and PSA 1.05+0.65 ng/ml. During the first 4 weeks, there was a steady increase in pre-injection T from 19.14+3.48 to 23.89+9.15 nmol/l (p¼0.1). However, after 8 weeks the post-injection T (25.77+7.67 nmol/l) remained similar to that of week 1 (27.46+12.91 nmol/l). Patients tolerated this therapy with no adverse effects.
Conclusions:
A once-week SC injection of 50–100 mg of TE appears to achieve sustainable and stable levels of physiological T. This technique offers fewer physician visits and the use of a smaller quantity of medication, thus lower costs. However, the long-term clinical and physiological effects of this therapy need further evaluation.
I also attached a 2006 pilot study.....other recent studies have been done between 2006-2019!